OK MPJE flashcards
OK MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Durham-Humphrey Amendment
- Federal 1951 amendment that created the prescription-only drug class and required the legend 'Caution: Federal law prohibits dispensing without prescription' on those products.
- Poison Prevention Packaging Act
- Requires child-resistant packaging for most oral prescription drugs and selected OTC products; prescribers or patients may request non-child-resistant packaging, with certain drugs excluded by rule.
- Combat Meth Act purchase limits
- Federal limits on scheduled listed chemical products: 3.6 grams of pseudoephedrine or ephedrine per purchaser per day and 9 grams per 30-day period, sold behind the counter with identification and a logbook.
- Oklahoma pharmacy statutes
- Oklahoma's Pharmacy Practice Act appears in Title 59 of the Oklahoma Statutes, section 353 et seq.; implementing Board of Pharmacy rules are in Title 535 of the Oklahoma Administrative Code.
- OBRA 1990 counseling rule
- Federal Medicaid requirement that pharmacies offer to counsel each patient on new and refilled prescriptions, with the offer and any refusal documented in the patient record.
- DEA Form 224
- Application for a new DEA registration, used by pharmacies, practitioners, and distributors; a registration must exist for each location before controlled substances are handled there.
- DEA registration renewal cycle
- DEA registrations are renewed every three years, generally using Form 224a; the current certificate must be kept at the registered location and available for inspection.
- Oklahoma OBNDD registration
- Oklahoma requires a separate controlled dangerous substances registration from the Oklahoma Bureau of Narcotics and Dangerous Drugs Control, in addition to the federal DEA registration, before controlled drugs may be handled.
- DEA Form 106
- Report of theft or significant loss of controlled substances filed with the DEA field office within one business day of discovery, with copies retained and parallel notice to state and local authorities.
- NAPLEX and MPJE
- National examinations required for pharmacist licensure: NAPLEX assesses pharmacotherapy knowledge and MPJE assesses federal and state pharmacy law; Oklahoma requires both plus internship and application requirements.
- Emergency oral Schedule II order
- A pharmacist may fill an oral Schedule II prescription in a genuine emergency for the quantity needed during the emergency, provided the prescriber delivers a written prescription within seven days.
- Generic substitution rule
- A pharmacist may substitute a therapeutically equivalent generic product unless the prescriber writes 'dispense as written' or the patient refuses, following Oklahoma substitution and patient notification requirements.
- Required prescription elements
- A valid prescription includes patient name and address, drug, strength, dosage form, quantity, directions, date, prescriber name and address, DEA number when controlled, and prescriber signature.
- Naloxone standing order
- Oklahoma permits pharmacists to dispense naloxone without an individual patient prescription under a statewide standing order, with instructions to the patient or caregiver on overdose recognition and response.
- Pharmacist protocol authority
- Oklahoma pharmacists may provide defined services such as immunizations and naloxone under protocols or standing orders; authority outside those defined functions requires a patient-specific prescription from a licensed prescriber.
- DEA Form 222
- Order form, or its CSOS electronic equivalent, required to purchase Schedule I and Schedule II controlled substances; Schedule III through V purchases are documented by invoices instead.
- Biennial controlled substance inventory
- Every registrant takes an initial inventory and a biennial inventory every two years afterward, counting Schedule II items exactly and recording the date, time, and whether the pharmacy was open or closed.
- Schedule II partial fill
- Partial filling of a Schedule II prescription is allowed when the pharmacist cannot supply the full quantity, with the remainder supplied within 72 hours; long-term care or terminally ill patients may receive the remainder within 60 days.
- Refill limits for Schedule III-V
- A maximum of five refills may be dispensed within six months of the date the prescription was issued; after six months or after the authorized refills are used, a new prescription is required.
- DEA Form 41
- Form documenting the destruction of controlled substances, often executed through a registered reverse distributor, listing drug, strength, quantity, and signatures of the persons witnessing the destruction.
- Corresponding responsibility
- The pharmacist filling a controlled substance prescription shares legal responsibility with the prescriber for its legitimacy and must resolve red flags before dispensing the order.
- Prescription filing rules
- Schedule II prescriptions are filed separately from other prescriptions; Schedule III through V and noncontrolled prescriptions are filed separately or kept readily retrievable for the required retention period.
- Beyond-use date
- The date after which a compounded preparation must not be used, assigned according to USP 795 or USP 797 limits based on the type of preparation, water content, and storage conditions.
- USP 797
- Standards for compounding sterile preparations, covering cleanroom classification, environmental monitoring, personnel training and qualification, and assignment of beyond-use dates based on the risk level of the preparation.
- Technician task limits
- Registered pharmacy technicians perform duties delegated by the pharmacist but may not counsel patients, exercise independent professional judgment, or perform the final check on a filled prescription.
- Prescription label requirements
- Labels must show pharmacy name and address, prescription number, date, patient name, prescriber, directions, quantity, refills, required cautionary statements, and beyond-use or expiration information.
- Record retention two years
- Federal law requires controlled substance records such as prescriptions, inventories, invoices, and order forms to be kept two years and made available for inspection by authorized federal and state agents.
- Offer to counsel documentation
- The pharmacist must offer counseling on new and refill prescriptions; documenting the offer and the patient's refusal in the patient record demonstrates compliance with OBRA 1990 counseling requirements.
- Prospective drug utilization review
- A review completed before dispensing that screens for therapeutic duplication, drug interactions, allergies, incorrect dose or duration, and abuse or misuse, with the pharmacist resolving each alert.
- Oklahoma PMP reporting
- Oklahoma's prescription monitoring program, administered by the Oklahoma Bureau of Narcotics and Dangerous Drugs Control, collects controlled substance dispensing data submitted by Oklahoma pharmacies.
- Opioid acute pain limit
- Oklahoma law limits an initial opioid prescription written for acute pain to a seven-day supply, subject to statutory exceptions for defined conditions and clinical circumstances.
- Immunization documentation
- Pharmacists administering vaccines record the vaccine, dose, date, site, lot, and manufacturer, provide the patient a record, and report the administration to Oklahoma's immunization registry (OSIIS).